Table 5.
Surrogate Subtype | Subgroup | ER | PR | HER2 | Tumor Grade | Ki-67 (%) | ||
---|---|---|---|---|---|---|---|---|
Luminal A-like | + | +/− | − | and | G1, G2 | or | Low (<20%) | |
Luminal B-like | HER2 negative | + | +/− | − | and | G3 | or | High (≥20%) |
HER2 positive | + | +/− | + | G1, G2, G3 | Any value | |||
HER2 positive (non-luminal) | − | − | + | G1, G2, G3 | Any value | |||
Triple negative | − | − | − | G1, G2, G3 | Any value |
ER: estrogen receptor; HER2: human epidermal growth factor receptor 2; IHC: immunohistochemistry; Ki-67: proliferation marker; PR: progesterone receptor.